Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer

Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer

Masayuki Takeda1, Isamu Okamoto1, Yasumasa Nishimura2, Kazuhiko Nakagawa11Department of Medical Oncology, 2Department of Radiation Oncology, Kinki University Faculty of Medicine, Osaka, JapanAbstract: The epidermal growth factor receptor (EGFR) is a promising therapeutic target in non-small cell lun...

Full description

Bibliographic Details
Main Authors:	Takeda M, Okamoto I, Nishimura Y, Nakagawa K
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-10-01
Series:	Lung Cancer : Targets and Therapy
Online Access:	http://www.dovepress.com/nimotuzumab-a-novel-monoclonal-antibody-to-the-epidermal-growth-factor-a8470

Similar Items

Nimotuzumab, an Anti-EGFR Monoclonal Antibody, in the Treatment of Nasopharyngeal Carcinoma
by: Renba Liang MD, et al.
Published: (2021-01-01)

Dual Targeting of the Epidermal Growth Factor Receptor Using Combination of Nimotuzumab and Erlotinib in Advanced Non-Small-Cell Lung Cancer with Leptomeningeal Metastases: A Report of Three Cases
by: Xu H, et al.
Published: (2020-01-01)

Internalization, Intracellular Trafficking, Biodistribution of Monoclonal Antibody 806: A Novel Anti-Epidermal Growth Factor Receptor Antibody
by: Rushika M. Perera, et al.
Published: (2007-12-01)

The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
by: William Boland, et al.
Published: (2010-11-01)

The role of epidermal growth factor receptor in non-small cell lung cancer
by: Ayşe Feyda Nursal
Published: (2015-03-01)

The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutations
by: Isamu Okamoto, et al.
Published: (2010-09-01)

MAXIMIZATION OF DNA DAMAGE TO MGMT(+) EGFR(+) GBM CELLS USING OPTIMAL COMBINATION OF TEMOZOLOMIDE-ANTI EGFR MONOCLONAL ANTIBODY NIMOTUZUMAB
by: M. A. M. Inggas, et al.
Published: (2015-09-01)

Clinical Translation and Validation of a Predictive Biomarker for Patritumab, an Anti-human Epidermal Growth Factor Receptor 3 (HER3) Monoclonal Antibody, in Patients With Advanced Non-small Cell Lung Cancer
by: Jeanne Mendell, et al.
Published: (2015-03-01)

EFFICACY EVALUATION OF A MONOCLONAL ANTIBODY AGAINST THE EPIDERMAL GROWTH FACTORS RECEPTOR IN THE MODEL OF SUBCUTANEOUS XENOGRAFT IN IMMUNODEFICIENT MICE
by: Ya. Yu. Ustyugov, et al.
Published: (2016-02-01)

Construction of an immunotoxin by linking a monoclonal antibody against the human epidermal growth factor receptor and a hemolytic toxin
by: ANA D AVILA, et al.
Published: (2007-01-01)

Monoclonal Antibody–Conjugated Superparamagnetic Iron Oxide Nanoparticles for Imaging of Epidermal Growth Factor Receptor–Targeted Cells and Gliomas
by: Ketao Mu, et al.
Published: (2015-05-01)

Immunotherapy in Epidermal Growth Factor Receptor-mutant  Non-small Cell Lung Cancer
by: Xin WANG, et al.
Published: (2019-08-01)

Epidermal Growth Factor Receptor Mutations and Radiotherapy  in Non-small Cell Lung Cancer
by: Xing ZHONG, et al.
Published: (2013-03-01)

Study of intransigence of the epidermal growth factor receptor in non-small cell lung cancer
by: Teesta Katte, et al.
Published: (2021-01-01)

Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
by: Giuliano Palumbo, et al.
Published: (2020-04-01)

GENETICS AND IMMUNOLOGICAL CHARACTERIZATION OF EPIDERMAL GROWTH FACTOR RECEPTORS AND THEIR RELATION TO THE MECHANISM OF CELL GROWTH CONTROL (MONOCLONAL ANTIBODY, TUMOR, RICIN TOXIN).
by: Behzadian, Mohammad Ali
Published: (1984)

CROSSTALK BETWEEN CANNABINOID RECEPTORS AND EPIDERMAL GROWTH FACTOR RECEPTOR IN NON-SMALL CELL LUNG CANCER
by: Ravi, Janani
Published: (2015)

Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair
by: Teng K, et al.
Published: (2015-04-01)

Resistance mechanisms to epidermal growth factor receptor inhibitors in non-small cell lung cancer
by: Suresh Kumar Bondili, et al.
Published: (2020-01-01)

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
by: Connor O’Leary, et al.
Published: (2020-09-01)

Detection of Mutations in Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Patients
by: Ji Ci Jhou, et al.
Published: (2009)

Effect of nimotuzumab targeted therapy combined with conventional chemotherapy in treatment of advanced non-small cell lung cancer
by: Hai-Ping Xu, et al.
Published: (2016-03-01)

A novel epidermal growth factor receptor inhibitor for treating lung cancer
by: Jiansheng Gao, et al.
Published: (2017-03-01)

The Monoclonal Antibody CH12 Enhances the Sorafenib-Mediated Growth Inhibition of Hepatocellular Carcinoma Xenografts Expressing Epidermal Growth Factor Receptor Variant III
by: Yaqiong Yang, et al.
Published: (2012-06-01)

The mechanisms between cigarette smoking and desensitizes epidermal growth factor receptor - expressing non-small cell lung cancer to epidermal growth factor receptor - tyrosine kinase inhibitors
by: Chih-Yen Tu, et al.
Published: (2018)

Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancer
by: Linda Leung, et al.
Published: (2012-07-01)

Prognostic value of epidermal growth factor receptor expression in operable non-small cell lung carcinoma
by: Seyhan Ekrem, et al.
Published: (2010-10-01)

Epidermal Growth Factor Receptor Mutational Status and Brain Metastases in Non–Small-Cell Lung Cancer
by: Vijaya Raj Bhatt, et al.
Published: (2017-06-01)

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer
by: William J. Kelly, et al.
Published: (2018-07-01)

Optimal Therapeutic Strategy for Non-small Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor
by: Zhong SHI, et al.
Published: (2015-02-01)

Quantitative Biomarkers for Prediction of Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer
by: Liwen Zhang, et al.
Published: (2018-02-01)

Monoclonal Antibodies to the Thyrotropin Receptor
by: Takao Ando, et al.
Published: (2005-01-01)

Fragmentation of Nimotuzumab for Preparation of 125I-F(ab’)2-Nimotuzumab as a Precursor for Preparing 125I-F(ab’)2-Nimotuzumab-NLS Radiopharmaceutical for Cancer Therapy
by: R.D. Haryuni, et al.
Published: (2014-04-01)

Characterizing and engineering antibodies against the epidermal growth factor receptor
by: Chao, Ginger
Published: (2008)

Inhibition of fibroblast growth factor receptor 3-dependent lung adenocarcinoma with a human monoclonal antibody
by: Yongjun Yin, et al.
Published: (2016-05-01)

Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma
by: Chen Chen, et al.
Published: (2020-03-01)

Clinical development of nintedanib for advanced non-small-cell lung cancer
by: Takeda M, et al.
Published: (2015-11-01)

Epidermal growth factor receptor-mutant non-small cell lung Cancer and Choroidal metastases: long-term outcome and response to epidermal growth factor receptor tyrosine kinase inhibitors
by: Clémentine Bouchez, et al.
Published: (2020-12-01)

Epidermal growth factor receptor tyrosine kinase inhibitors with conventional chemotherapy for the treatment of non-small cell lung cancer
by: Gao Y, et al.
Published: (2015-12-01)

Diagnostic value of mutation-specific antibodies for immunohistochemical detection of epidermal growth factor receptor mutations in non-small cell lung cancer: a meta-analysis.
by: Zi Chen, et al.
Published: (2014-01-01)